| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.27B | 13.82B | 13.04B | 11.93B | 10.89B |
| Gross Profit | 0.00 | 4.61B | 4.46B | 4.14B | 3.75B |
| EBITDA | 1.19B | 1.49B | 1.37B | 1.20B | 1.16B |
| Net Income | 259.40M | 295.70M | 431.20M | 363.40M | 306.60M |
Balance Sheet | |||||
| Total Assets | 10.11B | 8.82B | 8.68B | 9.10B | 9.44B |
| Cash, Cash Equivalents and Short-Term Investments | 1.01B | 1.15B | 1.03B | 1.08B | 1.22B |
| Total Debt | 3.42B | 2.94B | 3.13B | 3.63B | 3.81B |
| Total Liabilities | 6.89B | 5.87B | 5.85B | 6.28B | 6.53B |
| Stockholders Equity | 3.06B | 2.94B | 2.83B | 2.81B | 2.91B |
Cash Flow | |||||
| Free Cash Flow | 453.40M | 806.10M | 872.40M | 619.60M | 1.12B |
| Operating Cash Flow | 1.03B | 1.31B | 1.30B | 1.03B | 1.38B |
| Investing Cash Flow | -381.40M | -696.10M | -435.30M | -516.60M | -245.70M |
| Financing Cash Flow | -511.60M | -773.60M | -909.80M | -643.80M | -595.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £3.06B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
70 Outperform | £14.82B | 7.98 | 52.86% | 1.80% | 12.80% | 23.60% | |
68 Neutral | £3.67B | 9.49 | 15.14% | 1.21% | 10.51% | -9.26% | |
65 Neutral | £1.55B | 6.72 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | £7.06B | 26.69 | 0.69% | 1.18% | 25.02% | -14.15% | |
54 Neutral | £279.98M | -0.65 | -155.17% | ― | -15.00% | 21.71% |